Hsa-mir-124-3p, a downregulated miRNA predicted to bind to CDKN2A, is considered a key miRNA in CCRCC, inhibiting tumor migration, invasion, and proliferation (Butz et al., 2015). This evidence concerns the gene CDKN2A and nonpapillary renal cell carcinoma.